Market Cap 2.86B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 18,343,701
Avg Vol 7,604,734
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 89%
Beta 1.20
Analysts Strong Sell
Price Target $10.75

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Treb3k
Treb3k Aug. 12 at 12:52 PM
$EDSA $ABCL is doing a $200M raise after a run from about $5 - $9. can we just reflect on how wild it is that Edesa did not do this? during a run from $1 - $6 the CEO was buying on the open market. the stock then ran to $8 and $15 - $18 and there was no raise. back to $8. and back to $5 before a very small PIPE which was again funded by the CEO… Im honestly not sure it is a good thing, considering the company has a financing issue… But it is surely interesting.
0 · Reply
CrestFresh
CrestFresh Aug. 12 at 12:47 PM
$ABCL good day to recover from the company getting well funded for phase 3 😎
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Aug. 12 at 12:42 PM
$ABCL 12 soon
0 · Reply
Dbern7
Dbern7 Aug. 12 at 12:28 PM
$ABCL well timed offering. Will need the cash to ramp manufacturing. Only 300 million shares, this has a negligible impact on stock price long term, and an immediate impact on scalability short term. Great job by management
0 · Reply
armerius
armerius Aug. 12 at 12:28 PM
$ABCL Shorts are working extra hard to find an easy exit
1 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 12:19 PM
$ABCL My advice is to buy puts for 6.00 SP Then go long if you want funds tied up for years
1 · Reply
Olg59
Olg59 Aug. 12 at 12:19 PM
$ABCL Where delution comes from They have plenty of cash
0 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High Aug. 12 at 12:16 PM
$ABCL Price for the offering is key. 20M shares is nothing as long as its sold at good price. Currently ABCL is significantly undervalued so selling at higher prices make more sense. Such sudden announcement means they are going aggressively towards expediting the pipeline development which is great news.
0 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 12:12 PM
$ABCL Price action matters. If shorts anticipated a financing-driven retracement, the low $9 LIQUIDITY sweep and rapid recovery could indicate that thesis is already being challenged. FDA uncertainty remains, but ABCL now has strong clinical validation, substantial capital, major pharmaceutical relationships and growing regulatory expertise therefore a much stronger position from which to tackle the next phase.
0 · Reply
kingGstark
kingGstark Aug. 12 at 12:11 PM
$ABCL It's so funny how bears try to scare people here just to move the market so they can make some money. Quite pathetic.
0 · Reply
Latest News on ABCL
AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 16 hours ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 23 hours ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 2 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 2 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 2 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 2 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 6 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 6 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 5 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 5 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 5 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 2 months ago

AbCellera appoints Victor Sandor to board of directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 3 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


Treb3k
Treb3k Aug. 12 at 12:52 PM
$EDSA $ABCL is doing a $200M raise after a run from about $5 - $9. can we just reflect on how wild it is that Edesa did not do this? during a run from $1 - $6 the CEO was buying on the open market. the stock then ran to $8 and $15 - $18 and there was no raise. back to $8. and back to $5 before a very small PIPE which was again funded by the CEO… Im honestly not sure it is a good thing, considering the company has a financing issue… But it is surely interesting.
0 · Reply
CrestFresh
CrestFresh Aug. 12 at 12:47 PM
$ABCL good day to recover from the company getting well funded for phase 3 😎
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Aug. 12 at 12:42 PM
$ABCL 12 soon
0 · Reply
Dbern7
Dbern7 Aug. 12 at 12:28 PM
$ABCL well timed offering. Will need the cash to ramp manufacturing. Only 300 million shares, this has a negligible impact on stock price long term, and an immediate impact on scalability short term. Great job by management
0 · Reply
armerius
armerius Aug. 12 at 12:28 PM
$ABCL Shorts are working extra hard to find an easy exit
1 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 12:19 PM
$ABCL My advice is to buy puts for 6.00 SP Then go long if you want funds tied up for years
1 · Reply
Olg59
Olg59 Aug. 12 at 12:19 PM
$ABCL Where delution comes from They have plenty of cash
0 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High Aug. 12 at 12:16 PM
$ABCL Price for the offering is key. 20M shares is nothing as long as its sold at good price. Currently ABCL is significantly undervalued so selling at higher prices make more sense. Such sudden announcement means they are going aggressively towards expediting the pipeline development which is great news.
0 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 12:12 PM
$ABCL Price action matters. If shorts anticipated a financing-driven retracement, the low $9 LIQUIDITY sweep and rapid recovery could indicate that thesis is already being challenged. FDA uncertainty remains, but ABCL now has strong clinical validation, substantial capital, major pharmaceutical relationships and growing regulatory expertise therefore a much stronger position from which to tackle the next phase.
0 · Reply
kingGstark
kingGstark Aug. 12 at 12:11 PM
$ABCL It's so funny how bears try to scare people here just to move the market so they can make some money. Quite pathetic.
0 · Reply
HeIsHavingHisBath
HeIsHavingHisBath Aug. 12 at 12:10 PM
$ABCL Everyone knows how much cash they have on hand, so what's the problem here in grabbing a little more to help them cross the finish line? Seems like a standard and smart thing to do.
0 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 12:07 PM
$ABCL Company obviously worried about offering price That’s why was not disclosed! Not good for bulls! 6.00 Cometh
1 · Reply
JennyRowes
JennyRowes Aug. 12 at 11:58 AM
$ABCL total equity raises look to be about 800M, so this raise will it to 1B equity financing with 700 M cash in the bank. Not bad!!
1 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 11:47 AM
$ABCL Also worth noting: that same day saw the highest trading volume in ABCL’s entire history. That’s a pretty significant detail not to overlook.
0 · Reply
tradersunion353
tradersunion353 Aug. 12 at 11:45 AM
$ABCL overhpyped underperforming junk clowns here just exaggerate every negative news clowns deserve a crash to pre phase 2 range 6 dollars
0 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 11:40 AM
$ABCL The only number they’ve actually put out so far is $9.32. This is a public offering, so there’s no special pricing advantage for private investors. And that $9.32 was the closing price on the very day ABCL hit a 52-week high; a pretty significant detail given the company’s entire trading history.
1 · Reply
Bazziggr
Bazziggr Aug. 12 at 11:40 AM
$ABCL JUNK
0 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 11:35 AM
$ABCL They had set offering price at 5.00 Volume dried up after 200m dagger🤣
2 · Reply
toni1965
toni1965 Aug. 12 at 11:29 AM
$ABCL They are gonna place 25 m shares at $8/sh.
3 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 11:09 AM
$ABCL The share versus pre-funded warrant structure is also revealing. Economically, they are nearly equivalent, yet warrants sacrifice immediate voting rights. That makes the eventual mix, along with 13D/13G filings, warrant exercises and float changes, potentially very informative about who wants economic exposure versus voting influence.
0 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 11:06 AM
$ABCL Phase 2 200m offer = 💩
0 · Reply
tradersunion353
tradersunion353 Aug. 12 at 11:06 AM
$ABCL as this pos will crash today clowns here get hysteric with bullish statement this is best offering i am selling my house going homeless and adding in abcl clowns., true clowns
1 · Reply